Turku University Hospital — Sponsor Intelligence | 22 EU Trials

Filter these 22 trials by condition, phase, country and more.

Open in Search →

22 Registered trials

8 Recruiting

2 Completed trials

4 Countries active

36 Unique IMPs

100% Results reported

Phase II

Phase IV

Phase III: 1 Phase II/III: 1 Phase II: 8 Phase I/II: 1 Phase IV: 10 Phase I (FiH): 1

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Bladder cancer 1 Testicular seminoma (pure) 1 Head and neck cancer 1 Glioblastoma multiforme 1

Top IMPs

[AL[18F]F]FAPI-74 4 PIFLUFOLASTAT (18F) 2 AUTOLOGOUS ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION 1 BCG (BACILLUS CALMETTE-GUÉRIN) BACTERIA 1 BLEOMYCIN SULFATE PH. EUR. 1 BUPIVACAINE HYDROCHLORIDE 1 CAPECITABINE 1 CARBOPLATIN 1 CISPLATIN 1 CYCLOPHOSPHAMIDE 1 ETOPOSIDE 1 ETOPOSIDE PHOSPHATE 1

All trials

22 total

Oral Antibiotic Outpatient Therapy vs. Placebo in the Treatment of Uncomplicated Acute Appendicitis Pending

2023-506213-21-00 Phase IV 1 country
Molecular theranostics for metastatic prostate cancer: PSMA, FAPI, or both? Pending

2024-511104-16-00 Phase II 1 country [AL[18F]F]FAPI-74; PIFLUFOLASTAT (18F)
Diagnosing Vesicoureteric Reflux in Children by Direct Isotope Cystography and Contrast Enhanced Voiding Ultrasonography Pending

2024-518974-15-01 Phase IV 1 country SULFUR HEXAFLUORIDE; TECHNETIUM (99MTC)
Optimizing the antibiotic treatment of uncomplicated acute appendicitis - APPAC II Pending

2024-518984-36-00 Phase IV 1 country
Chemoimmunotherapy in conjunction with blood-brain-barrier opening in patients with newly diagnosed or relapsed primary central nervous syst… Pending

2024-519046-79-00 Phase II 1 country CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE PHOSPHATE; METHOTREXATE; RITUXIMAB
Acute appendicitis and microbiota – etiology and effects of the antimicrobial treatment - MAPPAC Pending

2024-519392-26-00 Phase IV 1 country
POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY STUDY FOR SAFETY, TOLERABILITY, BIODISTRIBUTION AND PERFORMANCE OF [68Ga]Ga-DOTA-SIGLEC-9 F… Pending

2024-519864-42-00 Phase I (FiH) 1 country
The usage of unenriched emulsified fat transplant in temporomandibular joint degenerative diseases Pending

2024-520244-41-00 Phase II 1 country AUTOLOGOUS ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION
Antibiotic therapy vs. placebo in the treatment of acute uncomplicated appendicitis: a prospective randomized double-blind placebo-controlle… Pending

2025-520761-44-00 Phase IV 1 country
Sequential Chemotherapy regimen with vinorelbine and cisplatin plus PET-guided stereotactic ablative radiotherapy (SABR) for castration- and… Pending

2025-521551-23-01 Phase I/II 1 country
Post-operative analgesia and spinal block duration following total hip arthroplasties Pending

2025-522358-38-02 Phase IV 1 country BUPIVACAINE HYDROCHLORIDE; ROPIVACAINE HYDROCHLORIDE
The Expression of Fibroblast Activation Protein in Patients with Non-Small Cell Lung Cancer Patients Pending

2025-523965-97-00 Phase II 1 country [AL[18F]F]FAPI-74
Intranasal dexmedetomidine sedation and analgesia during pediatric emergency room procedures Recruiting

2024-518816-38-00 Phase IV 1 country
Diagnostic efficacy of 18F-FAPI-74 PET/CT in patients with colon cancer Recruiting

2024-510651-35-00 Phase II 1 country [AL[18F]F]FAPI-74
Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer Recruiting

2023-510208-39-00 Phase II 1 country [AL[18F]F]FAPI-74
The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Quality of Life Recruiting

2024-513437-21-00 Phase IV 1 country BLEOMYCIN SULFATE PH. EUR.; CAPECITABINE; CISPLATIN; ETOPOSIDE; GEMCITABINE; IFO…
LSTA1 for subjects with newly diagnosed Glioblastoma Multiforme when added to standard of care (temozolomide) versus temozolomide Recruiting

2023-506813-23-00 Phase II 3 countries LSTA1; TEMOZOLOMIDE
99mTc-MIP-1404 SPECT/CT for primary PROstate cancer STAging: comparative prospective, randomized trial to present guideline imaging, PROSTAM… Recruiting

2024-516083-28-00 Phase II/III 1 country PIFLUFOLASTAT (18F); TROFOLASTAT
The effect of androgen deprivation therapy on the expression of prostate specific membrane antigen (PSMA) in treatment naive metastatic pros… Recruiting

2024-519516-14-01 Phase II 1 country
Intravesical instillation therapy with bacillus Calmette-Guérin (BCG) and sequential BCG and electromotive mitomycin-C (EMDA-MMC) in patient… Recruiting

2024-516320-33-00 Phase III 1 country BCG (BACILLUS CALMETTE-GUÉRIN) BACTERIA; MITOMYCIN
Vancomycin treatment in critically ill adults using model-informed precision dosing tool – prospective low-intervention clinical trial. (Pro… Ended

2023-509003-32-00 Phase IV 1 country
Treatment of non-type 2 CRSwNP with anti-IL-17 antibody (secukinumab) Ended

2023-505711-20-00 Phase IV 1 country SECUKINUMAB

Showing 1–22 of 22 trials

← All sponsors A–Z